Bile acids and cardiovascular function in cirrhosis

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Bile acids and cardiovascular function in cirrhosis. / Voiosu, Andrei; Wiese, Signe; Voiosu, Theodor; Bendtsen, Flemming; Møller, Søren.

I: Liver International, Bind 37, Nr. 10, 10.2017, s. 1420-1430.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Voiosu, A, Wiese, S, Voiosu, T, Bendtsen, F & Møller, S 2017, 'Bile acids and cardiovascular function in cirrhosis', Liver International, bind 37, nr. 10, s. 1420-1430. https://doi.org/10.1111/liv.13394

APA

Voiosu, A., Wiese, S., Voiosu, T., Bendtsen, F., & Møller, S. (2017). Bile acids and cardiovascular function in cirrhosis. Liver International, 37(10), 1420-1430. https://doi.org/10.1111/liv.13394

Vancouver

Voiosu A, Wiese S, Voiosu T, Bendtsen F, Møller S. Bile acids and cardiovascular function in cirrhosis. Liver International. 2017 okt.;37(10):1420-1430. https://doi.org/10.1111/liv.13394

Author

Voiosu, Andrei ; Wiese, Signe ; Voiosu, Theodor ; Bendtsen, Flemming ; Møller, Søren. / Bile acids and cardiovascular function in cirrhosis. I: Liver International. 2017 ; Bind 37, Nr. 10. s. 1420-1430.

Bibtex

@article{b98be402125c4a708f5ffd252b5321ea,

title = "Bile acids and cardiovascular function in cirrhosis",

abstract = "Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.",

author = "Andrei Voiosu and Signe Wiese and Theodor Voiosu and Flemming Bendtsen and S{\o}ren M{\o}ller",

note = "{\textcopyright} 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",

year = "2017",

month = oct,

doi = "10.1111/liv.13394",

language = "English",

volume = "37",

pages = "1420--1430",

journal = "Liver International",

issn = "1478-3223",

publisher = "Wiley-Blackwell",

number = "10",

}

RIS

TY - JOUR

T1 - Bile acids and cardiovascular function in cirrhosis

AU - Voiosu, Andrei

AU - Wiese, Signe

AU - Voiosu, Theodor

AU - Bendtsen, Flemming

AU - Møller, Søren

PY - 2017/10

Y1 - 2017/10

N2 - Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.

AB - Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.

U2 - 10.1111/liv.13394

DO - 10.1111/liv.13394

M3 - Review

C2 - 28222247

VL - 37

SP - 1420

EP - 1430

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 10

ER -

ID: 195012277